WVE

Wave Life Sciences Stock Analysis

AI Rating

Good
  • Quality6/10
  • Growth↓ 4/10
  • Momentum↑ 9/10
Wave Life Sciences sales and earnings growth
WVE Growth
Neutral
  • Revenue Y/Y↑ 103.75%
  • EPS Y/Y↑ 41.44%
  • FCF Y/Y↓ -39.73%
Wave Life Sciences gross and profit margin trends
WVE Profitability
Good
  • Gross margin ↑ 100.00%
  • EPS margin↓ -111.60%
  • ROIC↑ 504.40%
Wave Life Sciences net debt vs free cash flow
WVE Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Wave Life Sciences stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗